Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black women.
作者： Matthew Schlumbrecht , Marilyn Huang , Judith Hurley , Sophia George
关键词:
摘要: Purpose Data on endometrial cancer outcomes among immigrant women in the USA are lacking. The objective was to determine effect of Caribbean nativity black with compared born USA, attention paid effects tumor grade, sociodemographic factors, and treatment approaches. Methods A review institutional registry performed identify black, non-Hispanic known treated for between 2001 2017. Sociodemographic, treatment, data were collected. Analyses done using χ2 test, Cox proportional hazards models, Kaplan–Meier method, significance set at P Results 195 included analysis. High grade histologies present a large proportion both US (64.5%) (72.2%) patients. Compared women, those more likely be non-smokers (P=0.01) uninsured (P=0.03). had cases stage III disease (27.8% versus 12.5%, Conclusions prevalence high is higher than previously reported. may associated improved overall survival although additional study warranted.
elsevier.com
sci-hub.st 参考文章(29)
B. Long, F.W. Liu, R.E. Bristow, Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States Gynecologic Oncology. ,vol. 130, pp. 652- 659 ,(2013) , 10.1016/J.YGYNO.2013.05.020
Luisa N. Borrell, Delivette Castor, Francine P. Conway, Mary Beth Terry, Influence of Nativity Status on Breast Cancer Risk Among US Black Women Journal of Urban Health-bulletin of The New York Academy of Medicine. ,vol. 83, pp. 211- 220 ,(2006) , 10.1007/S11524-005-9014-5
M. Trottier, J. Lunn, R. Butler, D. Curling, T. Turnquest, W. Francis, D. Halliday, R. Royer, S. Zhang, S. Li, I. Thompson, T. Donenberg, J. Hurley, M. R. Akbari, S. A. Narod, Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas. Clinical Genetics. ,vol. 89, pp. 328- 331 ,(2016) , 10.1111/CGE.12602
A Nguyen, Z Desta, D A Flockhart, Enhancing race-based prescribing precision with pharmacogenomics. Clinical Pharmacology & Therapeutics. ,vol. 81, pp. 323- 325 ,(2007) , 10.1038/SJ.CLPT.6100080
A F Abraído-Lanza, B P Dohrenwend, D S Ng-Mak, J B Turner, The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses. American Journal of Public Health. ,vol. 89, pp. 1543- 1548 ,(1999) , 10.2105/AJPH.89.10.1543
Jan V. Bokhman, Two pathogenetic types of endometrial carcinoma Gynecologic Oncology. ,vol. 15, pp. 10- 17 ,(1983) , 10.1016/0090-8258(83)90111-7
K Lindemann, L J Vatten, M Ellstrøm-Engh, A Eskild, Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. British Journal of Cancer. ,vol. 98, pp. 1582- 1585 ,(2008) , 10.1038/SJ.BJC.6604313
Zachary Nicholas, Nan Hu, Jian Ying, Patrick Soisson, Mark Dodson, David K. Gaffney, Impact of comorbid conditions on survival in endometrial cancer. American Journal of Clinical Oncology. ,vol. 37, pp. 131- 134 ,(2014) , 10.1097/COC.0B013E318277D5F4
Carien L Creutzberg, Wim LJ van Putten, Peter CM Koper, Marnix LM Lybeert, Jan J Jobsen, Carla C Wárlám-Rodenhuis, Karin AJ De Winter, Ludy CHW Lutgens, Alfons CM van den Bergh, Elzbieta van de Steen-Banasik, Henk Beerman, Mat van Lent, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial The Lancet. ,vol. 355, pp. 1404- 1411 ,(2000) , 10.1016/S0140-6736(00)02139-5
RA Nout, VTHBM Smit, H Putter, IM Jürgenliemk-Schulz, JJ Jobsen, LCHW Lutgens, EM van der Steen-Banasik, JWM Mens, A Slot, MC Stenfert Kroese, BNFM van Bunningen, AC Ansink, WLJ van Putten, CL Creutzberg, Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial The Lancet. ,vol. 375, pp. 816- 823 ,(2010) , 10.1016/S0140-6736(09)62163-2